BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 35820906)

  • 21. CLEC5A expression can be triggered by spike glycoprotein and may be a potential target for COVID-19 therapy.
    Machado TL; Santos AC; Azamor T; da Silva AMV; Pimenta VR; Tubarão LN; da Silva ADS; Flores Rodrigues DDR; Müller R; Pinto MA; Villar LM; Bom APA; Melgaço JG
    J Med Virol; 2023 Jan; 95(1):e28427. PubMed ID: 36571274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 primed platelets-derived microRNAs enhance NETs formation by extracellular vesicle transmission and TLR7/8 activation.
    Liao TL; Liu HJ; Chen DY; Tang KT; Chen YM; Liu PY
    Cell Commun Signal; 2023 Oct; 21(1):304. PubMed ID: 37904132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19: Lung-Centric Immunothrombosis.
    Kvietys PR; Fakhoury HMA; Kadan S; Yaqinuddin A; Al-Mutairy E; Al-Kattan K
    Front Cell Infect Microbiol; 2021; 11():679878. PubMed ID: 34178722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy.
    Nicolai L; Leunig A; Brambs S; Kaiser R; Weinberger T; Weigand M; Muenchhoff M; Hellmuth JC; Ledderose S; Schulz H; Scherer C; Rudelius M; Zoller M; Höchter D; Keppler O; Teupser D; Zwißler B; von Bergwelt-Baildon M; Kääb S; Massberg S; Pekayvaz K; Stark K
    Circulation; 2020 Sep; 142(12):1176-1189. PubMed ID: 32755393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High Levels of Neutrophil Extracellular Traps Persist in the Lower Respiratory Tract of Critically Ill Patients With Coronavirus Disease 2019.
    Ouwendijk WJD; Raadsen MP; van Kampen JJA; Verdijk RM; von der Thusen JH; Guo L; Hoek RAS; van den Akker JPC; Endeman H; Langerak T; Molenkamp R; Gommers D; Koopmans MPG; van Gorp ECM; Verjans GMGM; Haagmans BL
    J Infect Dis; 2021 May; 223(9):1512-1521. PubMed ID: 33507309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19.
    Bonaventura A; Vecchié A; Dagna L; Martinod K; Dixon DL; Van Tassell BW; Dentali F; Montecucco F; Massberg S; Levi M; Abbate A
    Nat Rev Immunol; 2021 May; 21(5):319-329. PubMed ID: 33824483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A functionally distinct neutrophil landscape in severe COVID-19 reveals opportunities for adjunctive therapies.
    Panda R; Castanheira FV; Schlechte JM; Surewaard BG; Shim HB; Zucoloto AZ; Slavikova Z; Yipp BG; Kubes P; McDonald B
    JCI Insight; 2022 Jan; 7(2):. PubMed ID: 34908534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelets and COVID-19.
    Rohlfing AK; Rath D; Geisler T; Gawaz M
    Hamostaseologie; 2021 Oct; 41(5):379-385. PubMed ID: 34695854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stem Cell Extracellular Vesicles as Anti-SARS-CoV-2 Immunomodulatory Therapeutics: A Systematic Review of Clinical and Preclinical Studies.
    Ahmed SH; AlMoslemany MA; Witwer KW; Tehamy AG; El-Badri N
    Stem Cell Rev Rep; 2024 May; 20(4):900-930. PubMed ID: 38393666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preventing the development of severe COVID-19 by modifying immunothrombosis.
    Morris G; Bortolasci CC; Puri BK; Olive L; Marx W; O'Neil A; Athan E; Carvalho A; Maes M; Walder K; Berk M
    Life Sci; 2021 Jan; 264():118617. PubMed ID: 33096114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracellular Vesicle Associated miRNAs Regulate Signaling Pathways Involved in COVID-19 Pneumonia and the Progression to Severe Acute Respiratory Corona Virus-2 Syndrome.
    Meidert AS; Hermann S; Brandes F; Kirchner B; Buschmann D; Billaud JN; Klein M; Lindemann A; Aue E; Schelling G; Pfaffl MW; Reithmair M
    Front Immunol; 2021; 12():784028. PubMed ID: 34956213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin.
    Qian Y; Lei T; Patel PS; Lee CH; Monaghan-Nichols P; Xin HB; Qiu J; Fu M
    J Virol; 2021 Nov; 95(23):e0139621. PubMed ID: 34549987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutrophil Extracellular Traps (NETs) in Severe SARS-CoV-2 Lung Disease.
    Szturmowicz M; Demkow U
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions.
    Root-Bernstein R
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Emerging Role of Neutrophils in the Pathogenesis of Thrombosis in COVID-19.
    Iliadi V; Konstantinidou I; Aftzoglou K; Iliadis S; Konstantinidis TG; Tsigalou C
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A specific low-density neutrophil population correlates with hypercoagulation and disease severity in hospitalized COVID-19 patients.
    Morrissey SM; Geller AE; Hu X; Tieri D; Ding C; Klaes CK; Cooke EA; Woeste MR; Martin ZC; Chen O; Bush SE; Zhang HG; Cavallazzi R; Clifford SP; Chen J; Ghare S; Barve SS; Cai L; Kong M; Rouchka EC; McLeish KR; Uriarte SM; Watson CT; Huang J; Yan J
    JCI Insight; 2021 May; 6(9):. PubMed ID: 33986193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-sustaining IL-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19.
    Kaiser R; Leunig A; Pekayvaz K; Popp O; Joppich M; Polewka V; Escaig R; Anjum A; Hoffknecht ML; Gold C; Brambs S; Engel A; Stockhausen S; Knottenberg V; Titova A; Haji M; Scherer C; Muenchhoff M; Hellmuth JC; Saar K; Schubert B; Hilgendorff A; Schulz C; Kääb S; Zimmer R; Hübner N; Massberg S; Mertins P; Nicolai L; Stark K
    JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34403366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detrimental Role of Neutrophil Extracellular Traps during Dengue Virus Infection.
    Schulz C; Gabriel G; von Köckritz-Blickwede M
    Trends Immunol; 2020 Jan; 41(1):3-6. PubMed ID: 31791719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thromboplasminflammation in COVID-19 Coagulopathy: Three Viewpoints for Diagnostic and Therapeutic Strategies.
    Gando S; Wada T
    Front Immunol; 2021; 12():649122. PubMed ID: 34177896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Casting a wide NET: an update on uncontrolled NETosis in response to COVID-19 infection.
    Taylor EB
    Clin Sci (Lond); 2022 Jul; 136(13):1047-1052. PubMed ID: 35791847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.